ANNOUNCEMENT
ASCCP Presents Dr. Tom Cox with Lifetime Achievement Award
South San Francisco, CA – May 5, 2023 – Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of pre-cancerous lesions caused by human papilloma virus (HPV) infection, is thrilled to congratulate our valued clinical advisor, Dr. J. Thomas Cox, on receiving the Lifetime Achievement Award from the American Society for Colposcopy and Cervical Pathology on May 5, 2023. Dr. Cox is recognized as being an outstanding gynecologist who has pioneered research in HPV and cervical cancer screening over his 40-plus year career. Throughout that time, he has been a strong advocate for patients and HPV research. We are so lucky to have him as part of our team, congratulations, Tom!
About Antiva Biosciences
Antiva Biosciences, Inc. is a clinical-stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company, based in South San Francisco, was founded in 2012 by Dr. Karl Hostetler of The University of California San Diego. The company’s lead drug candidate,
Contact
Kristine Ball
Antiva Biosciences, Inc.
650-822-1400
info@antivabio.com
Tim Brons
Vida Strategic Partners (media)
646-319-8981
tbrons@vidasp.com
